ArticleVaccines2023

Preliminary Study on the Efficacy of a Recombinant, Subunit SARS-CoV-2 Animal Vaccine against Virulent SARS-CoV-2 Challenge in Cats.

Igor Morozov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.